Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MicroRNA expression data from APPswe/PS1deltaE9 transgenic mice cortex

ABSTRACT: To characterize the differentially expressed microRNAs between APPswe/PS1deltaE9 transgenic mice cortex and normal wild type mice cortex

ORGANISM(S): Mus musculus

PROVIDER: GSE55589 | GEO | 2015/03/05

SECONDARY ACCESSION(S): PRJNA240172

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MicroRNA expression data from APPswe/PS1deltaE9 transgenic mice cortex

Project description:To characterize the differentially expressed microRNAs between APPswe/PS1deltaE9 transgenic mice cortex and normal wild type mice cortex We isolated APPswe/PS1delataE9 and wild type mice brain cortexes for microRNA sequencing.

2015-03-05 | E-GEOD-55589 | biostudies-arrayexpress

prefrontal cortex (ctrl vs transgenic synaptic AChE)

Project description:total prefrontal cortex RNA in female FVB/N mice (control) versus transgenic female mice overexpressing the human synaptic AChE Keywords: other

2004-05-01 | GSE937 | GEO

Mus musculus

Project description:MicroRNA expression data from APPswe/PS1deltaE9 transgenic mice cortex

| PRJNA240172 | ENA

Transcription profiling of mouse prefrontal cortex (ctrl vs transgenic synaptic AChE)

Project description:total prefrontal cortex RNA in female FVB/N mice (control) versus transgenic female mice overexpressing the human synaptic AChE

2008-06-16 | E-GEOD-937 | biostudies-arrayexpress

Proteome profiling in APP/PS1 mice brain and modulation by tocotrienol-rich fraction

Project description:This study examined the proteome profile in the hippocampus, medial prefrontal cortex, and striatum of APPswe/PS1dE9 transgenic mice (APP/PS1) model of Alzheimer’s disease compared to wild-type mice. The effect of tocotrienol-rich fraction (TRF), a mixture of vitamin E analogs derived from palm oil supplementation on the proteome profile of APP/PS1 mice hippocampus, medial prefrontal cortex, and striatum was also investigated. The analysis was performed using ultrahigh-performance liquid chromatography coupled with Q Exactive HF Orbitrap mass spectrometry. This study was in hoped to understand the mechanisms of Alzheimer’s disease at proteome level, and pre-emptive activity of TRF to combat the disease.

2019-12-06 | PXD011068 | Pride

Brain proteome analysis of APPswe mouse model at the early stages of Alzheimer's disease pathology

Project description:Plaques consisting of amyloid-Î² (AÎ²) in the brain are characteristic for patients with AlzheimerÂ´s disease. AÎ² is enzymatically generated of the amyloid precursor protein (APP). During the disease, AÎ² starts to aggregate forming soluble oligomers, soluble protofibrils and eventually insoluble fibrils. AÎ² pathology starts mainly at the hippocampus and the surrounding cortical area. Mice overexpressing the Aï�¢-precursor protein with the Swedish mutation (APPswe) are one of the most commonly used animal models in Alzheimerâ€™s field. These mice overexpress APP with the Swedish mutation (KM670/671NL), which is adjacent to the Î²-secretase cleavage site on APP. This results in increased production of AÎ². The aim of this study was to study the proteome of APPswe brain at the early stages (7-8 months old) of the disease, before plaque onset, which starts at around 11-12 months of age in this mouse model. Homogenates of the hippocampus and the rest of the cerebrum from 7-8 months-old APPswe and wild-type (WT) controls were lysed. Afterwards, filter aided tryptic digestion was performed. The resulting peptides were analyzed using LC-UDMSE. The data was searched against a randomized mouse database and label-free quantification analysis was done. In total 2487 proteins were found. In the hippocampus of APPswe mice, the levels of 1283 proteins were significantly altered compared to WT controls. While 1379 proteins were significantly altered in the rest of the cerebrum of APPswe mice compared to WT controls. Among these, mitochondrial proteins and proteins involved in neuron's development were significantly downregulated, suggesting mitochondrial dysfunction and dysregulation of neuronâ€™s growth in the brain of APPswe mice at already this stage of the disease.

2021-06-28 | PXD026566 | Pride

Total and MicroRNA from transgenic mice

Project description:Total and MicroRNA from transgenic mice

| PRJNA329140 | ENA

Expression data from Alzheimer's disease model mouse

Project description:To identify molecular pathological alterations in AD brains, we performed interspecies comparative microarray analyses using RNAs prepared from postmortem human brain tissues donated for the Hisayama study and hippocampal RNAs from the triple-transgenic mouse model of AD (3xTg-AD) Three-way ANOVA of microarray data from frontal cortex, temporal cortex and hippocampus with presence/absence of AD and vascular dementia, and sex, as factors revealed that the gene expression profile is most significantly altered in the hippocampi of AD brains. Comparative analyses of the brains of AD patients and a mouse model of AD showed that genes involved in non-insulin dependent DM and obesity were significantly altered in both, as were genes related to psychiatric disorders and AlzheimerM-bM-^@M-^Ys disease. 3xTg-AD-H mice harboring a homozygous Psen1M146V mutation and homozygous mutant transgenes for APPSwe and tauP301L, 3xTg-AD-h mice harboring hemizygous APPSwe and tauP301L transgenes with a homozygous Psen1M146V mutation, and non-transgenic control mice (non-Tg) were used in this study, (male, n=3 for each group). RNA samples prepared from hippocampi were subjected to microarray analysis using the Affymetrix Mouse Gene 1.0 ST platform (GPL6246).

2013-04-17 | E-GEOD-36981 | biostudies-arrayexpress

MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice

Project description:Synaptic plasticity impairment plays a critical role in the pathogenesis of Alzheimer’s disease (AD), and emerging evidence has shown that microRNAs (miRNAs) are alternative biomarkers and therapeutic targets for synaptic dysfunctions in AD. In this study, we found that the level of miR-431 was downregulated in the plasma of amnestic mild cognitive impairment (aMCI) and AD patients. In addition, it was decreased in the hippocampus and plasma of APPswe/PS1dE9 (APP/PS1) mice. Lentivirus mediated miR-431 overexpression in the hippocampus CA1 ameliorated synaptic plasticity and memory deficits of APP/PS1 mice, while it didn't affect the Aβ levels. Smad4 was identified as a target of miR-431, and Smad4 knockdown modulated the expression of synaptic proteins including SAP102, and protected against synaptic plasticity and memory dysfunctions in APP/PS1 mice. Furthermore, Smad4 overexpression reversed the protective effects of miR-431, indicating that miR-431 attenuated synaptic impairment at least partially by Smad4 inhibition. Thus, these results indicated that miR-431/Smad4 might be a potential therapeutic target for AD treatment.

2023-05-15 | GSE231985 | GEO

LncRNA/mRNA sequencing analysis on cerebral cortex of P301S mutant Tau transgenic mice (PS19).

Project description:LncRNA/mRNA sequencing analysis on cerebral cortex of P301S mutant Tau transgenic mice (PS19).

| PRJNA485768 | ENA